Temozolomide in combination with fotemustine in patients with metastatic melanoma.

Tas, Faruk; Camlica, Hakan; Topuz, Erkan

Tas, Faruk; Camlica, Hakan; Topuz, Erkan.

Affiliation

Tas F; Institute of Oncology, Istanbul University, Capa, 34390, Istanbul, Turkey. faruktas2002@yahoo.com

Cancer Chemother Pharmacol ; 62(2): 293-8, 2008 Jul.

Article in En | MEDLINE | ID: mdl-17909803

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Melanoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Dacarbazine/administration & dosage; Dacarbazine/adverse effects; Dacarbazine/analogs & derivatives; Dacarbazine/therapeutic use; Disease-Free Survival; Female; Humans; Male; Melanoma/drug therapy; Melanoma/mortality; Melanoma/secondary; Middle Aged; Neoplasm Staging; Nitrosourea Compounds/administration & dosage; Nitrosourea Compounds/adverse effects; Nitrosourea Compounds/therapeutic use; Organophosphorus Compounds/administration & dosage; Organophosphorus Compounds/adverse effects; Organophosphorus Compounds/therapeutic use; Temozolomide

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Melanoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article

Search on Google

XML

PubMed Links